Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes Elke S. Bergmann-LeitnerScott I. Abrams Original Article Pages: 445 - 455
Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity J. Li L. Holmes Y. Wei Original Article Pages: 456 - 462
Dendritic cells pulsed with tumor extract–cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor Hideo AokiMasaaki MizunoJun Yoshida Original Article Pages: 463 - 468
A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells Ingvil SæterdalMarianne K. GjertsenGustav Gaudernack Original Article Pages: 469 - 476
Biodistribution of 111indium-labeled macrophages infused intravenously in patients with renal carcinoma Véronique QuillienAnnick MoisanLouis Toujas Original Article Pages: 477 - 482
Soluble ICAM-1 in breast cancer: clinical significance and biological implications Wolfgang J. KöstlerSandra TomekChristoph C. Zielinski Original Article Pages: 483 - 490
Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma Pontus HegardtBengt WidegrenHans Sjögren Original Article Pages: 491 - 501